
One quarter of breast cancer cases belong to two subtypes that are difficult to treat. EU-funded researchers are identifying new therapeutic targets for these patient groups. The research has already led to new diagnostic tools, while patients are already being enrolled for clinical trials.
from EUROPA - Syndicated Research News Feed http://ift.tt/1FZ02yp
via
IFTTT
No comments:
Post a Comment